Targeting the TLR2 Receptor With a Novel Thymopentin-Derived Peptide Modulates Immune Responses.
Wei X, Zhang L, Zhang R, Wu R, Petitte JN, Hou Y, Si D, Ahmad B, Guo H, Zhang M, Cheng Q, Tong Y.
Wei X, et al. Among authors: zhang l, zhang m, zhang r.
Front Immunol. 2021 May 27;12:620494. doi: 10.3389/fimmu.2021.620494. eCollection 2021.
Front Immunol. 2021.
PMID: 34122400
Free PMC article.